Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Diagnostic solutions697.63M35.50%
Sample technologies662.99M33.73%
Polymerase Chain Reaction (PCR) / Nucleic acid amplification300.2M15.28%
Genomics / Next-Generation Sequencing (NGS)238.91M12.16%
Other65.58M3.34%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States935.28M47.59%
Europe, Middle East and Africa604.27M30.75%
Asia Pacific, Japan and Rest of World320.68M16.32%
Other Americas84.77M4.31%
Netherlands20.3M1.03%
